International COVID-19 Blood Cancer Coalition (ICBCC)

June 21, 2022

A multi-stakeholder coalition consisting of representatives from the global patient advocacy and clinical community has formed the International COVID-19 Blood Cancer Coalition (ICBCC) to address the specific impact of the pandemic on immunocompromised blood cancer patients (both acute and chronic), like those living with acute leukemia and to recommend solutions and actions to mitigate those risks. 

The coalition calls on researchers and policy makers to make vaccines available to everyone, prioritize research and equitable access to testing and protective antibody treatments to the vulnerable, and maintaining masking and social distancing in high-risk circumstances. 

Our colleagues from CLL Advocates Network (CLLAN) are leading the secretariat on behalf of the coalition.

The coalition has prepared a Joint Patient Impact Statement for use in different countries to aid when advocating for the provision of anti-COVID-19 treatment and care for immunocompromised or immunosuppressed (IC/IS) blood cancer patients.

The Statement has by now been endorsed by 73 networks and national organisations of the global patient advocacy community as well as 16 renowned medical societies and representatives from the global clinical community.

List of endorsers: Endorsers

Also, ICBCC´s global campaign toolkit is available for download to help raise awareness of the vulnerability and needs of the immunocompromised blood cancer community around COVID-19 prevention and treatment. The toolkit consists of:

Campaign materials: https://www.icbcc.info/campaign-materials/

It would be great if you shared the campaign’s social media posts using #ICBCC and #considerthecompromised

For more information on the coalition, visit ICBCC website : https://www.icbcc.info/